Is Buying TRXADE GROUP INC (OTCMKTS:TRXD), Having Lower Short Interest a Winning Strategy?

October 13, 2018 - By whatsonthorold

Trxade Group, Inc. (OTCMKTS:TRXD) Logo

The stock of TRXADE GROUP INC (OTCMKTS:TRXD) registered a decrease of 50% in short interest. TRXD’s total short interest was 400 shares in October as published by FINRA. Its down 50% from 800 shares, reported previously. With 5,100 shares average volume, it will take short sellers 0 days to cover their TRXD’s short positions.

It closed at $0.42 lastly. It is down 0.00% since October 13, 2017 and is . It has underperformed by 15.62% the S&P500.

Trxade Group, Inc. owns and operates a business-to-business Web marketplace focused on the United States pharmaceutical industry. The company has market cap of $13.56 million. The firm offers Web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. It has a 42 P/E ratio. The Company’s principal services and products include and, which are Web pharmaceutical marketplaces; Pharmabayonline that provides access to proprietary pharmaceutical data analytics to the United States independent pharmacies, pharmaceutical shortage databases, proposed governmental reimbursement benchmarks comparison and analysis, and a proprietary suggested national retail drug benchmark; and RxGuru, a service desktop software application, which provides daily drug pricing and analytics to the independent pharmacists.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News